NEW YORK, Aug. 7 – Bruker Daltonics reported second-quarter 2001 revenues of $22.3 million, compared with $17.5 million the company posted one year ago, as it continued to record strong sales of its mass spectrometers designed to analyze proteins and other biomolecules.

Sales of Bruker Daltonics’ life science mass spectrometry systems contributed to 75 percent of the company’s total revenue, with substance detection and aftermarket revenue contributing the remainder.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.